EV/EBITDA
-361.48
+16.48+4.36%
Wed, 18 Dec 2024 23:10:57 GMT
Summary:
Alnylam Pharmaceuticals EV/EBITDA is currently -361.48, with a rise of +16.48 (+4.36%) during the most recent trading day. Over the past year, it has dropped by -257.00 (-245.98%). ALNY EV/EBITDA is now -260.44% below its all-time high of 225.31.ALNY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +4.4% |
| 1 m1 month | -1.5% |
| 3 m3 months | -270.2% |
| 6 m6 months | -79.9% |
| ytdytd | -232.8% |
| 1 y1 year | -246.0% |
| 5 y5 years | -2065.8% |
ALNY EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -351.41 | -2.9% | -388.85 | +7.0% |
| 3 m | 3 months | 215.94 | -267.4% | -434.71 | +16.9% |
| 6 m | 6 months | 225.31 | -260.4% | -434.71 | +16.9% |
| 1 y | 1 year | 225.31 | -260.4% | -434.71 | +16.9% |
| 3 y | 3 years | 225.31 | -260.4% | -434.71 | +16.9% |
| 5 y | 5 years | 225.31 | -260.4% | -434.71 | +16.9% |
| alltime | all time | 225.31 | -260.4% | -434.71 | +16.9% |
Alnylam Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -361.48(+232.8%) |
| 2023 | -108.62(+227.8%) |
| 2022 | -33.14(-0.2%) |
| 2021 | -33.19(+52.5%) |
| 2020 | -21.76(+43.9%) |
| 2019 | -15.12(+61.4%) |
| 2018 | -9.37(-62.0%) |
| 2017 | -24.68(+218.5%) |
| 2016 | -7.75(-72.6%) |
| 2015 | -28.27(-34.3%) |
| Date | Value |
|---|---|
| 2014 | -43.03(-12.0%) |
| 2013 | -48.91(+194.3%) |
| 2012 | -16.62(+197.3%) |
| 2011 | -5.59(-36.8%) |
| 2010 | -8.84(-39.5%) |
| 2009 | -14.62(-66.8%) |
| 2008 | -43.97(+203.5%) |
| 2007 | -14.49(-23.3%) |
| 2006 | -18.89(+119.9%) |
| 2005 | -8.59(+79.7%) |
| 2004 | -4.78 |
FAQ
- What is Alnylam Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Alnylam Pharmaceuticals?
- What is ALNY EV/EBITDA year-to-date change?
- What is Alnylam Pharmaceuticals EV/EBITDA year-on-year change?
What is Alnylam Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ALNY is -361.48
What is the all time high EV/EBITDA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high EV/EBITDA is 225.31
What is ALNY EV/EBITDA year-to-date change?
Alnylam Pharmaceuticals EV/EBITDA has changed by -252.86 (-232.79%) since the beginning of the year
What is Alnylam Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ALNY EV/EBITDA has changed by -257.00 (-245.98%)